TED
Clinical trials for TED explained in plain language.
Never miss a new study
Get alerted when new TED trials appear
Sign up with your email to follow new studies for TED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection tested to fight bulging eyes and double vision
Disease control OngoingThis study is testing whether satralizumab, an injectable medication, can help control moderate-to-severe thyroid eye disease. About 131 participants will receive either the drug or a placebo to see if it reduces eye bulging, double vision, pain, and improves quality of life. The…
Matched conditions: TED
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
First human test begins for new drug candidate
Knowledge-focused ENROLLING_BY_INVITATIONThis is a very early study to see if a new injection called NTB003 is safe for people and to learn how the body handles it. It will involve 40 healthy volunteers who will receive different doses. The main goal is to check for side effects and measure the drug's levels in the bloo…
Matched conditions: TED
Phase: PHASE1 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC